Navigation Links
Favrille to Report New Data on FavId (Now Specifid) at American Society of Hematology Annual Meeting
Date:12/6/2007

p>"We continue to be encouraged by the long-term follow-up data from this trial, particularly in the treatment-naive and complete remission populations," said Richard Ghalie, M.D., Favrille's Chief Medical Officer. "These data reaffirm our confidence in our pivotal Phase 3 trial of Specifid following Rituxan, which has a high proportion of each of the populations who appear to benefit the most. We look forward to the primary endpoint data in our Phase 3 trial next summer and ultimately to advancing this important therapy to the marketplace so that it may be made broadly available to patients in need."

Additional Specifid-related posters at the ASH Annual Meeting will include:

-- A presentation by Dr. John Timmerman from the University of California,

Los Angeles on Sunday will present data comparing Id-KLH active

immunotherapy generated in insect cells (Specifid) to Id-KLH produced

in a traditional mammalian cell manufacturing process. The analysis

concludes that Id-KLH produced via insect cells results in a more

immunogenic response in a number of in vitro and in vivo assays, and

may lead to improved activity of the final Id-KLH active immunotherapy

product.

-- A presentation by Dr. David Maloney of the Fred Hutchinson Cancer

Research Center on Monday analyzing the role of Fc receptor

polymorphisms on the outcome of treatment with Rituxan followed by

Specifid. The data suggest that long-term progression-free survival

following a treatment regimen of Rituxan plus Specifid does not

correlate with inheritance of particular Fc receptor polymorphisms nor

with the production of anti-idiotypic antibody and therefore may rely

more on a cell-mediated immune response.

A copy of each poster presentation will be available on Favrille's website at http://www.favrille.com
'/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Virginia Tech Report Has National Importance
2. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
3. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
4. Haemacure Reports Third Quarter 2007 Results
5. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
6. Biotech Finishes on a High in August, Burrill Report Says
7. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
8. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
9. MDS Reports Third Quarter 2007 Results
10. First New York/New Jersey Health Care Report Card Released
11. Authentidate Holding Corp. to Report Fourth Quarter and Fiscal 2007 Year End Results on Thursday, September 13, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... HealthDay Reporter THURSDAY, July ... kids don,t see themselves that way, which makes achieving ... a new study, 27 percent of children and teens ... About 25 percent of parents underestimated their child,s weight ... study. "Efforts to prevent childhood obesity should incorporate ...
(Date:7/31/2014)... of an algorithm aimed to diagnose pediatric patients ... tomography (CT) scans, without affecting diagnostic accuracy, Mayo ... was recently published in the journal Surgery ... cause of acute abdominal pain in children. Appendicitis ... with pus. CT scans are often used to ...
(Date:7/31/2014)... July 31, 2014 Joseph M. Lee, ... Hudson Valley (CDHV), a leading provider of quality cardiovascular ... Hudson Valley. Dr. Lee is a board certified ... , In addition to his position at CDHV, ... New York-Presbyterian Hospital/ Columbia University Medical Center. Dr. Lee ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Millions of ... Some have had traumatic experiences as a child and ... dental work. As a highly experienced NJ cosmetic ... experience anxiety during their dental procedure. To help ... experienced team at Champagne Smiles offer several sedation dentistry ...
(Date:7/31/2014)... 31, 2014 The VitalSleep anti snoring device is ... to help open a snorers airway to quiet snoring. , ... helped her relationship with her husband by allowing them to share ... old. My snoring began about 15 years ago and I remember ... could not sleep and had to head downstairs for any relief. ...
Breaking Medicine News(10 mins):Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 2Health News:1 in 4 U.S. Kids Underestimate Their Weight, Study Finds 3Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 2Health News:ColumbiaDoctors of the Hudson Valley Welcomes Joseph M. Lee, M.D., M.S., R.P.V.I. 3Health News:Champagne Smiles is Thrilled to Now Offer Sedation Dentistry to their Patients 2Health News:New Snoring Mouthpiece Reviews from VitalSleep 2
... stem cell transplantation (HDC-ASCT), for previously untreated patients ... overall survival compared with conventional-dose chemotherapy alone, according ... the Journal of the National Cancer ... common sub-type of non-Hodgkin,s lymphoma in North America, ...
... HealthDay Reporter , WEDNESDAY, Dec. 21 (HealthDay News) ... shakes and soup followed by adding low-calorie, high-protein foods ... may lessen joint pain and improve their quality of ... also help people whose obesity makes it impossible to ...
... (December 21, 2011) Autism Speaks, the world,s largest ... of 47 new research grants totaling $13,242,279 in funding ... not only respond to Autism Speaks funding priorities, but ... treatment and quality of life for individuals with autism ...
... that happen every day, the infant mortality rate in the ... While experts believe this is closely linked to the growing ... to make labor and delivery safer. Northwestern Medicine researchers ... health at delivery through closer monitoring of infant oxygen use ...
... The University of Western Ontario and Dr. Meir Stampfer of ... the American Medical Association (JAMA) argues that vitamin therapy still ... Vitamin B therapy was once widely used to lower ... the bloodstream was linked to increased risk of stroke and ...
... HealthDay Reporter , TUESDAY, Dec. 20 (HealthDay News) ... keep their blood pressure levels under control may add years ... those in the study who took medicine to lower their ... of dying from cardiovascular disease over a 20-year period, the ...
Cached Medicine News:Health News:Autologous stem cell transplantation does not improve os in patients with follicular lymphoma 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 3Health News:Autism Speaks awards 47 new research grants funding 2Health News:Autism Speaks awards 47 new research grants funding 3Health News:Autism Speaks awards 47 new research grants funding 4Health News:Autism Speaks awards 47 new research grants funding 5Health News:Autism Speaks awards 47 new research grants funding 6Health News:Autism Speaks awards 47 new research grants funding 7Health News:Autism Speaks awards 47 new research grants funding 8Health News:Northwestern researchers trial new device that may support improved newborn health 2Health News:Treating High Blood Pressure May Add Years to Life 2Health News:Treating High Blood Pressure May Add Years to Life 3
(Date:7/31/2014)... Inc. (NYSE: RMD ) today announced results for ... 30, 2014.  Revenue for the quarter was $415.2 million, flat ... percent decrease on a constant currency basis). Net income was ... quarter ended June 30, 2013. Diluted earnings per share for ... to the quarter ended June 30, 2013.  ...
(Date:7/31/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... quarter ended June 30, 2014. Financial Results for ... Revenue Total revenue for the quarter ended June 30, 2014 ... ended June 30, 2013 primarily due to IMBRUVICA ® ... Total revenue for the six months ended June 30, 2014 ...
(Date:7/31/2014)... VIEW, Calif. , July 31, 2014 /PRNewswire/ ... today provided an update on its pipeline and ... 2014, Alexza expects to initiate a Phase 2a ... is being developed for the management of patients ... two new Staccato -based product candidates for ...
Breaking Medicine Technology:RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 2RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 3RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 4RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 5RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 6RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 7RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 8RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 9RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 10RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 11RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 12RESMED Inc. Announces Results for the Fourth Quarter and Fiscal Year 2014 13Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6Pharmacyclics Reports Second Quarter 2014 Results 7Pharmacyclics Reports Second Quarter 2014 Results 8Pharmacyclics Reports Second Quarter 2014 Results 9Pharmacyclics Reports Second Quarter 2014 Results 10Pharmacyclics Reports Second Quarter 2014 Results 11Pharmacyclics Reports Second Quarter 2014 Results 12Pharmacyclics Reports Second Quarter 2014 Results 13Pharmacyclics Reports Second Quarter 2014 Results 14Pharmacyclics Reports Second Quarter 2014 Results 15Pharmacyclics Reports Second Quarter 2014 Results 16Pharmacyclics Reports Second Quarter 2014 Results 17Pharmacyclics Reports Second Quarter 2014 Results 18Pharmacyclics Reports Second Quarter 2014 Results 19Pharmacyclics Reports Second Quarter 2014 Results 20Pharmacyclics Reports Second Quarter 2014 Results 21Pharmacyclics Reports Second Quarter 2014 Results 22Pharmacyclics Reports Second Quarter 2014 Results 23Pharmacyclics Reports Second Quarter 2014 Results 24
... Data presented by CSL Behring today suggest ... reduced risk of infection and missed school or work among ... at the 2011 American Academy of Allergy, Asthma and Immunology ... , one performed in the United States and one in ...
... 2011 HistoRx, Inc., announced today that the U.S. ... the company,s methods for standardization of digital microscopy instruments ... reproducible data that precisely relates to biomarker concentrations in ... digital pictures of an anatomic pathology specimen, a slide ...
Cached Medicine Technology:Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies 2Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies 3Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies 4Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies 5Study Demonstrates Relationship Between Subcutaneous IgG (SCIg) Dosage and Clinical Outcomes With Hizentra® Treatment in Patients With Primary Immunodeficiencies 6HistoRx Receives Fundamental Patent on Standardization of Results In Digital Pathology 2HistoRx Receives Fundamental Patent on Standardization of Results In Digital Pathology 3
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
... the special needs of infants ... protects the littlest humans when ... vulnerable by providing the ideal ... of an infants body temperature ...
The design of the large pediatric underbody blanket conveniently warms the large child or small adult patient while allowing full access for surgeons and staff....
This pediatric blanket is a smaller version of the full body blanket, providing warmth to smaller patients during recovery....
Medicine Products: